Not finding it? Sign in to also search OpenAlex live.
-
Abstract A97: The inhibitory receptor NKG2A acts as a checkpoint on CD8 T cells in the context of cancer vaccines2020 Cancer Immunology Research conference-abstract Immunology and Microbiology Immune Cell Function and Interaction
Thorbald van Hall, Nadine van Montfoort, Linda Borst, Michael J. Korrer, Pascale André, Nicolai R. Wagtmann, +2 more
0citations -
Screening assay to monitor mono-ADP-ribosylhydrolase activity of viral macrodomains in cells2026 Communications Biology article Immunology and Microbiology interferon and immune responses Open access
Sarah Knapp, Verena Weber, Maud Verheirstraeten, Ani Sabcheva, Tanner Wright, Lea Herkens, +11 more
2citations -
A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase (JAK) Inhibitor
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Ruben A. Mesa, Rami S. Komrokji, Steffen Koschmieder, +10 more
8citations -
MYF3001: A Randomized Open Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy in Patients with Intermediate-2 or High-Risk Myelofibrosis Relapsed/Refractory to Janus Kinase Inhibitor
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +9 more
2citations -
P1048: MYF3001: A RANDOMIZED OPEN LABEL, PHASE 3 STUDY TO EVALUATE IMETELSTAT VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS REFRACTORY TO JANUS KINASE INHIBITOR
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +11 more
1citations -
A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 (Int-2) or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase Inhibitor (JAKi)
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +9 more
1citations -
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft2023 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Luca Vinci, Christian Flotho, Peter Noellke, Dirk Lebrecht, Riccardo Masetti, Válerie de Haas, +25 more
14citations -
P0118 Plasma proteomic signatures relate to disease course and intestinal immune responses, uncovering immunotypes among Crohn’s Disease and Ulcerative Colitis patients2026 Journal of Crohn s and Colitis conference-abstract Medicine Inflammatory Bowel Disease Open access
B Calado, Maud Heredia, Mohammed Charrout, Renz C. W. Klomberg, Daniëlle M.H. Barendregt, D H Hulleman-van Haaften, +6 more
0citations -
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma2023 The Journal of Experimental Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 3 patents
Irene L. M. Reijers, Disha Rao, Judith M. Versluis, Alexander Maxwell Menzies, Petros Dimitriadis, Michel W.J.M. Wouters, +20 more
80citations -
SMAD3 and p300 complex scaffolding by long non-coding RNA LIMD1-AS1 promotes TGF-β-induced breast cancer cell plasticity2025 Nucleic Acids Research article Biochemistry, Genetics and Molecular Biology Cancer-related molecular mechanisms research Open access
Chuannan Fan, Davy Cats, Olga Khorosjutina, Soniya Dhanjal, Bernhard Schmierer, Hailiang Mei, +2 more
7citations -
Immunomodulatory endothelial cells contribute to T-cell recruitment and activation via antigen presentation on MHC II2026 Cardiovascular Research article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases
Matteo Cartura, Blerina Aliraj, Witold G. Szymanski, C.-S. Park, Giulio Ferrario, Flávia Rezende, +15 more
3citations -
1181 Therapeutic vaccines consisting of cancer germline antigen-based synthetic long peptides are immunogenic in human hepatocellular carcinoma patients2022 Regular and Young Investigator Award Abstracts conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses Open access
Yannick Sebastiaan Rakké, Marij Schoenmaekers-Welters, Lisanne Noordam, Sanne Boekestijn, Luc Magré, Robbie J. Luijten, +12 more
0citations -
Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation2020 Clinical & Translational Immunology article Medicine Respiratory viral infections research Open access
Elisabeth A. van Erp, Anke J. Lakerveld, Erik de Graaf, Mads Delbo Larsen, Rutger M. Schepp, Agnes L. Hipgrave Ederveen, +7 more
37citations -
ASC Speck Formation after Inflammasome Activation in Primary Human Keratinocytes2021 Oxidative Medicine and Cellular Longevity article Biochemistry, Genetics and Molecular Biology Inflammasome and immune disorders Open access
Nikola Smatlik, Stefan K. Drexler, Marc Burian, Martin Röcken, Amir Sadegh Yazdi
24citations -
DNA damage independent inhibition of NF-κB transcription by anthracyclines2022 eLife article Biochemistry, Genetics and Molecular Biology NF-κB Signaling Pathways Open access
Ângelo Ferreira Chora, Dora C. S. Pedroso, Eleni Kyriakou, Nadja Pejanovic, Henrique G. Colaço, Raffaella Gozzelino, +20 more
16citations -
In Vivo Matrigel Plug Assay as a Potent Method to Investigate Specific Individual Contribution of Angiogenesis to Blood Flow Recovery in Mice13citations